EXAGEN INC. - COMMON S

Exagen Announces Appointment of John Aballi as CEO

17 Oct 2022 08:00:00 By Nasdaq GlobeNewswire

Exagen Announces Appointment of Andrew L. Concoff MD, FACR, CAQSM, as Chief Innovation Officer

04 Oct 2022 07:25:00 By Nasdaq GlobeNewswire

Exagen Announces Acceptance of Multiple Abstracts at ACR 2022 Annual Meeting

20 Sep 2022 15:05:00 By Nasdaq GlobeNewswire

Exagen Inc. Collaboration Leads to Characterization of Broad Autoreactivity in Severe COVID-19 Patients

01 Sep 2022 15:05:01 By Nasdaq GlobeNewswire

Exagen Initiates Study to Predict Rheumatoid Arthritis Drug Response (RADR) in Patients with RA

04 Aug 2022 15:06:00 By Nasdaq GlobeNewswire

Exagen Inc. Reports Second Quarter 2022 Results

04 Aug 2022 15:05:01 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference

25 Jul 2022 15:05:00 By Nasdaq GlobeNewswire

Exagen to Announce Second Quarter 2022 Financial Results on August 4, 2022

21 Jul 2022 15:05:00 By Nasdaq GlobeNewswire

Exagen Releases Largest Comparative Utility Study in Lupus Diagnostics Confirming AVISE® Lupus Delivers Unparalleled Utility

05 Jul 2022 07:25:00 By Nasdaq GlobeNewswire

Exagen Inc. Expands Coverage with MediNcrease

09 Jun 2022 07:25:00 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the William Blair 42nd Annual Growth Stock Conference

26 May 2022 15:05:00 By Nasdaq GlobeNewswire

Exagen Inc. Expands Coverage with Alivio Health, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE® Lupus

16 May 2022 15:05:00 By Nasdaq GlobeNewswire

Exagen Inc. Announces New PLA Code and Medicare Pricing for Proprietary AVISE® Lupus Test

11 May 2022 15:06:00 By Nasdaq GlobeNewswire

Exagen Inc. Reports First Quarter 2022 Results

11 May 2022 15:05:01 By Nasdaq GlobeNewswire

Exagen Announces Five-Week Campaign for Lupus Awareness Month

01 May 2022 11:00:00 By Nasdaq GlobeNewswire

Exagen to Announce First Quarter 2022 Financial Results on May 11, 2022

25 Apr 2022 15:05:00 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in Investor Summit Group’s Q2 Conference

20 Apr 2022 15:05:00 By Nasdaq GlobeNewswire

Exagen Inc. Expands In-Network Access with Evolutions Healthcare Systems

30 Mar 2022 07:25:00 By Nasdaq GlobeNewswire

Exagen Inc. Expands In-Network Benefit with Additional 22.7 Million Lives

22 Mar 2022 15:06:00 By Nasdaq GlobeNewswire

Exagen Inc. Reports Fourth Quarter and Full Year 2021 Results

22 Mar 2022 15:05:00 By Nasdaq GlobeNewswire